These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18834830)

  • 1. An audit to assess the impact of new directives about the use of aprotinin on re-exploration rates and blood product usage after adult cardiac surgery.
    Khan SA; Jayarajah M; Ahlijah B
    J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):445-6. PubMed ID: 18834830
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
    Parvizi R; Azarfarin R; Hassanzadeh S
    Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced re-exploration and blood product transfusion after the introduction of the Papworth haemostasis checklist†.
    Ali JM; Gerrard C; Clayton J; Moorjani N
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):729-736. PubMed ID: 30346507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 7. Aprotinin revisited.
    Deanda A; Spiess BD
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):998-1002. PubMed ID: 22795461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation.
    Balsara KR; Morozowich ST; Lin SS; Davis RD; Phillips-Bute BG; Hartwig M; Appel JZ; Welsby IJ
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):45-8. PubMed ID: 18669527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience.
    Bojan M; Boulat C; Peperstraete H; Pouard P
    Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery.
    Biancari F; Kinnunen EM; Kiviniemi T; Tauriainen T; Anttila V; Airaksinen JKE; Brascia D; Vasques F
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1618-1624. PubMed ID: 29338997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eComment: Re: Multi-modality blood conservation strategy in open heart surgery: an audit.
    Bockeria LA; Grigoryants RG
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):482-3. PubMed ID: 19687048
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes.
    Hall TS; Brevetti GR; Skoultchi AJ; Sines JC; Gregory P; Spotnitz AJ
    Ann Thorac Cardiovasc Surg; 2001 Dec; 7(6):352-7. PubMed ID: 11888475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin dosing: how much is enough?
    Niimi KS
    J Extra Corpor Technol; 2004 Dec; 36(4):384-90. PubMed ID: 15679284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.